Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis.


Journal

Neurochemistry international
ISSN: 1872-9754
Titre abrégé: Neurochem Int
Pays: England
ID NLM: 8006959

Informations de publication

Date de publication:
03 2023
Historique:
received: 12 12 2022
revised: 09 02 2023
accepted: 12 02 2023
pubmed: 17 2 2023
medline: 15 3 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

Hereditary transthyretin (TTR) amyloidosis (ATTRv) is characterized by TTR amyloid deposition in the peripheral nervous system. It remains unknown why variant TTR preferentially deposits in the peripheral nerves and dorsal root ganglia. We previously detected low levels of TTR expression in Schwann cells and established an immortalized Schwann cell line, TgS1, derived from a mouse model of ATTRv amyloidosis expressing the variant TTR gene. In the present study, the expression of TTR and Schwann cell marker genes was investigated in TgS1 cells by quantitative RT-PCR. TTR gene expression was markedly upregulated in TgS1 cells incubated in non-growth medium-Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. The expression levels of c-Jun, Gdnf and Sox2 were increased, while Mpz was downregulated, suggesting that TgS1 cells exhibit a repair Schwann cell-like phenotype in the non-growth medium. Western blot analysis revealed that TTR protein was produced and secreted by the TgS1 cells. Furthermore, downregulation of Hsf1 with siRNA induced TTR aggregates in the TgS1 cells. These findings indicate that TTR expression is markedly increased in repair Schwann cells, likely to promote axonal regeneration. Therefore, aged dysfunctional repair Schwann cells may cause the deposition of variant TTR aggregates in the nerves of patients with ATTRv.

Identifiants

pubmed: 36796540
pii: S0197-0186(23)00035-9
doi: 10.1016/j.neuint.2023.105507
pii:
doi:

Substances chimiques

Prealbumin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105507

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tatsufumi Murakami (T)

Department of Neurology, Kawasaki Medical School, Kurashiki, Okayama, 701-0192, Japan; Faculty of Rehabilitation, Kawasaki University of Medical Welfare, Kurashiki, Okayama, 701-0193, Japan. Electronic address: tatsum@med.kawasaki-m.ac.jp.

Yuri Ito (Y)

Faculty of Rehabilitation, Kawasaki University of Medical Welfare, Kurashiki, Okayama, 701-0193, Japan.

Kazunori Sango (K)

Diabetic Neuropathy Project, Department of Diseases and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan.

Kazuhiko Watabe (K)

Department of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, 181-8612, Japan.

Yoshihide Sunada (Y)

Department of Neurology, Kawasaki Medical School, Kurashiki, Okayama, 701-0192, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH